Temperature-sensitive bacterial pathogens generated by the substitution of essential genes from cold-loving bacteria: potential use as live vaccines

Temperature-sensitive (TS) viruses have been used for decades as vaccines capable of limited replication in their hosts. Although attenuated bacteria, such as the Bacille Calmette–Guérin anti-tuberculosis vaccine, have been used for almost a century, it is only recently that there has been progress in using TS bacterial strains as live vaccines. Decades of work on essential bacterial genes and the recent explosion in the number of available bacterial genomic sequences set the groundwork for the identification of essential genes from diverse bacteria. This knowledge has allowed for the substitution of essential genes from cold-loving bacteria into the chromosomes of pathogenic bacteria. Many of these gene substitutions generated TS pathogenic bacterial strains, and some were demonstrated to provide protective immunity in mice. This work opens the possibility of engineering many pathogenic bacteria to create TS strains that can be used as vaccines.

[1]  Martin Rosenberg,et al.  Identification of Critical Staphylococcal Genes Using Conditional Phenotypes Generated by Antisense RNA , 2001, Science.

[2]  Y. Saif,et al.  Efficacy of a commercial turkey coryza vaccine (Art-Vax) in turkey poults. , 1985, Avian diseases.

[3]  T. Benzinger,et al.  Heat regulation: homeostasis of central temperature in man. , 1969, Physiological reviews.

[4]  D. Baxby The origins of vaccinia virus. , 1977, The Journal of infectious diseases.

[5]  S. Kaufmann,et al.  Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. , 1996, Journal of immunology.

[6]  Howard Xu,et al.  A genome‐wide strategy for the identification of essential genes in Staphylococcus aureus , 2002, Molecular microbiology.

[7]  J. Simpson,et al.  Use of a live chlamydial vaccine to prevent ovine enzootic abortion , 1997, Veterinary Record.

[8]  G. Feller,et al.  Psychrophilic enzymes: hot topics in cold adaptation , 2003, Nature Reviews Microbiology.

[9]  T. Fuchs,et al.  Large‐scale identification of essential Salmonella genes by trapping lethal insertions , 2004, Molecular microbiology.

[10]  W. P. Allen IMMUNITY AGAINST TULAREMIA: PASSIVE PROTECTION OF MICE BY TRANSFER OF IMMUNE TISSUES , 1962, The Journal of experimental medicine.

[11]  C. Serié,et al.  A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results. , 1982, Journal of Infectious Diseases.

[12]  S. Kaufmann,et al.  Cytolytic T-cell responses to human dendritic cells and macrophages infected with Mycobacterium bovis BCG and recombinant BCG secreting listeriolysin. , 1999, Microbes and infection.

[13]  C. Schmerk,et al.  Essential genes from Arctic bacteria used to construct stable, temperature-sensitive bacterial vaccines , 2010, Proceedings of the National Academy of Sciences.

[14]  J. W. Campbell,et al.  Experimental Determination and System Level Analysis of Essential Genes in Escherichia coli MG1655 , 2003, Journal of bacteriology.

[15]  Vincent Schächter,et al.  A complete collection of single-gene deletion mutants of Acinetobacter baylyi ADP1 , 2008, Molecular systems biology.

[16]  R. Y. Morita,et al.  PSYCHROPHILIC BACTERIA , 1959, Bacteriological reviews.

[17]  R. Walker,et al.  Live attenuated versus inactivated influenza vaccine in infants and young children. , 2007, The New England journal of medicine.

[18]  H. T. Eigelsbach,et al.  Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. , 1961, Journal of immunology.

[19]  R. Germanier,et al.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. , 1975, The Journal of infectious diseases.

[20]  I. Orme,et al.  Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients , 1983, The Journal of experimental medicine.

[21]  T. Foster,et al.  Investigations towards an efficacious and safe strangles vaccine: submucosal vaccination with a live attenuated Streptococcus equi , 2000, Veterinary Record.

[22]  Stanley Falkow,et al.  Global Transposon Mutagenesis and Essential Gene Analysis of Helicobacter pylori , 2004, Journal of bacteriology.

[23]  C. Morrow,et al.  Production of temperature-sensitive clones of Mycoplasma synoviae for evaluation as live vaccines. , 1998, Avian diseases.

[24]  A. Souriau,et al.  Response of ewes to temperature-sensitive mutants of Chlamydia psittaci (var ovis) obtained by NTG mutagenesis. , 1983, Annales de recherches veterinaires. Annals of veterinary research.

[25]  V. Lorenzo Genes that move the window of viability of life: Lessons from bacteria thriving at the cold extreme , 2011 .

[26]  R. Kaul,et al.  A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate , 2007, Proceedings of the National Academy of Sciences.

[27]  G. Feller,et al.  Some like it cold: biocatalysis at low temperatures. , 2004, FEMS microbiology reviews.

[28]  Eric Haugen,et al.  Comprehensive transposon mutant library of Pseudomonas aeruginosa , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Feller,et al.  Psychrophilic enzymes: molecular basis of cold adaptation , 1997, Cellular and Molecular Life Sciences CMLS.

[30]  B. Dougherty,et al.  Identification of 113 conserved essential genes using a high-throughput gene disruption system in Streptococcus pneumoniae. , 2002, Nucleic acids research.

[31]  H. Maassab,et al.  The development of live attenuated cold‐adapted influenza virus vaccine for humans , 1999, Reviews in medical virology.

[32]  S. Kaufmann,et al.  Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis. , 2009, Vaccine.

[33]  J. Mekalanos,et al.  A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. Munier-Lehmann,et al.  Relationship between bacterial virulence and nucleotide metabolism: a mutation in the adenylate kinase gene renders Yersinia pestis avirulent. , 2003, The Biochemical journal.

[35]  S. Ehrlich,et al.  Essential Bacillus subtilis genes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Mekalanos,et al.  TnAraOut, A transposon-based approach to identify and characterize essential bacterial genes , 2000, Nature Biotechnology.

[37]  J. Deming,et al.  Psychrophiles and polar regions. , 2002, Current opinion in microbiology.

[38]  V. de Lorenzo Genes that move the window of viability of life: Lessons from bacteria thriving at the cold extreme , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[39]  R. North Importance of thymus-derived lymphocytes in cell-mediated immunity to infection. , 1973, Cellular immunology.

[40]  H. Maassab,et al.  Development and characterization of cold-adapted viruses for use as live virus vaccines. , 1985, Vaccine.

[41]  M. Clegg,et al.  No effect of skin temperature on human ventilation response to hypercapnia during light exercise with a normothermic core temperature , 2010, European Journal of Applied Physiology.

[42]  G. Mahairas,et al.  Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis , 1996, Journal of bacteriology.

[43]  Lihan K. Yan,et al.  Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. , 2000, The Journal of infectious diseases.

[44]  T. Taniyama,et al.  Protective efficacy of recombinant BCG Tokyo (Ag85A) in rhesus monkeys (Macaca mulatta) infected intratracheally with H37Rv Mycobacterium tuberculosis. , 2009, Tuberculosis.

[45]  L. Bao,et al.  Virulence, Immunogenicity, and Protective Efficacy of Two Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Strains Expressing the Antigen ESAT-6 from Mycobacterium tuberculosis , 2003, Infection and Immunity.

[46]  B. Haynes,et al.  Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates. , 2009, Vaccine.

[47]  E. Rubin,et al.  Genes required for mycobacterial growth defined by high density mutagenesis , 2003, Molecular microbiology.

[48]  C. Hutchison,et al.  Essential genes of a minimal bacterium. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[49]  I. Golovliov,et al.  Reintroduction of Two Deleted Virulence Loci Restores Full Virulence to the Live Vaccine Strain of Francisella tularensis , 2009, Infection and Immunity.